Cargando…
Current Status of Diagnostic Testing for SARS-CoV-2 Infection and Future Developments: A Review
The coronavirus disease 2019 (COVID-19) caused by a novel coronavirus, SARS-CoV-2, has infected more than 50.6 million individuals and caused over 1.2 million deaths globally, raising a major health concern. To date, no specific antiviral treatment or vaccine for COVID-19 has been approved by the Fo...
Autores principales: | Gao, Jing, Quan, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754691/ https://www.ncbi.nlm.nih.gov/pubmed/33332288 http://dx.doi.org/10.12659/MSM.928552 |
Ejemplares similares
-
SARS-CoV-2 Vaccine Development: Current Status
por: Poland, Gregory A., et al.
Publicado: (2020) -
Development of Diagnostic Tests for Detection of SARS-CoV-2
por: Nguyen, Ngan N. T., et al.
Publicado: (2020) -
Diagnostic Testing for SARS-CoV-2 Infection
por: Thomas, Emmanuel, et al.
Publicado: (2021) -
High‐throughput screening assays for SARS‐CoV‐2 drug development: Current status and future directions
por: Xu, Tuan, et al.
Publicado: (2021) -
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future
por: Baldanti, Fausto, et al.
Publicado: (2022)